Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides

NCT07504029 is registered in ClinicalTrials.gov with Chung Shan Medical University as lead sponsor.

NCT NCT07504029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07504029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides
Lead sponsor
Chung Shan Medical University
Phase
Not applicable
Overall status
Recruiting
Start date
March 13, 2026
Completion date
July 31, 2026
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

people with prediabetic